(PharmaNewsWire.Com, April 23, 2020 ) Medical Robots Transforming Healthcare is increasingly being adopted by hospitals and patients across the globe, particularly in the U.S. Demographic change, shortage of healthcare professionals, need to improve quality of life for the disabled and elderly, and need to improve surgical procedures coupled with the focus to develop technologically advanced robots are some of the factors expected to stimulate growth the adoption of medical robots.
Scope of the Report:
This report provides a qualitative assessment of the price variation in medical robots of varied types (surgical/rehabilitation/non-invasive radiosurgery/hospital & pharmacy), selection criteria of adopting medical robots from an end-user perspective, buying cycle, price wars, and cost-benefits offered by the robots based on existing research studies.
Medical robots are igniting interest of all the stakeholders in the healthcare industry physicians, health care professionals, providers, payers, technologists, planners and even the government. For instance, citing the benefits offered by rehabilitation robots, Japan’s Health Ministry has approved Cyberdyne’s HAL exoskeleton suit as a medical device thus covering it under the public health insurance system.
Medical Robots: Marketing & Promotions Strategies Adopted by Vendors
The application and technology form the two important components that guide the final pricing of a medical robot. For instance, the surgical robots for laparoscopic applications are most expensive as compared to surgical robots for other applications. In addition, technological variation further creates price variation, an example for which is the named Zeno R25 (rehabilitation robot by RoboKind) which is expected to be launched in retail space at a price tag of USD 2,700. To cut the cost in R25, the manufacturers reduced the number of motors below the waist from 12 to three while still allowing the robot to walk and turn.
Medical Robotics is a highly sophisticated technology that showcases slow adoption due to economic hurdles. However, medical robots have become an extremely popular topic over the last few years. Thus, the cost-benefit assessment has taken center stage in the industry and is dominating almost every conversation and headlining several conferences in the field of robotics.
The report has provided a cost-benefit assessment covering cost-benefit studies and industry opinion. The section provides a guideline to the stakeholders in understanding the investment structure and the cost-savings achieved through the use of each type of robot. To increase access to this expensive technology, manufacturers have been offering varied financing options to healthcare providers. Some of the options include leasing, pay-per-use, bundled payments, rental agreements, and expanded payment terms, among others.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
